Literature DB >> 2094667

Pediatric tuberculosis pyramid and its fate with and without chemotherapy/chemoprophylaxis.

P M Udani1.   

Abstract

The latest available information on total and infectious cases of tuberculosis in the country and also large number of sputum positive cases being detected annually, particularly after the involvement of multipurpose workers in the primary health care programme for the control of tuberculosis, is presented. The consequences of the large pool of infectious cases in the population lead to spread of bacilli to children with development of primary infection in them. These children with primary infection, specially high risk group in infancy and early childhood, get serious complications of the disease. It may be emphasized that BCG vaccination cannot prevent the lodgement of tubercle bacilli in the lung but can only contain or restrict haematogenous spread. Inspite of increasing coverage of infants with BCG vaccination there are an increasing number of cases of intrathoracic tuberculosis, particularly various groups of mediastinal nodes. However, to a lesser extent haematogenous complications do occur in malnourished children, as BCG has a limited value in preventing serious complications in children with malnutrition. The clinical pattern of pediatric tuberculosis has also changed in vaccinated and partly or inadequately drug treated children. Hence, chemoprophylaxis/chemotherapy to prevent complications of primary infection has been tried. Even relatively privileged children in developed countries are reported to have complications of primary infection to an extent of 10 to 15%, as per the studies all over world. So preventive chemoprophylaxis, preferably with two bactericidal drugs, should be considered as the main strategy for controlling primary infection. Chemoprophylaxis with two drugs should be used as incidence of isoniazid resistant bacilli has increased. All concerned with child health should consider the strategy of treatment of primary infection in high risk children by chemoprophylaxis by starting a large multicentric trial both in urban and rural areas, as a part and parcel of primary health care intervention already in practice for cases of sputum positive pulmonary tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2094667     DOI: 10.1007/bf02728704

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

1.  Prophylactic effects of isoniazid on primary tuberculosis in children; a preliminary report.

Authors:  S FEREBEE; F W MOUNT; A ANASTASIADES
Journal:  Am Rev Tuberc       Date:  1957-12

2.  Tuberculosis in young children.

Authors:  R M CAMMOCK; F J W MILLER
Journal:  Lancet       Date:  1953-01-24       Impact factor: 79.321

3.  The value of follow-up studies of children with primary tuberculosis.

Authors:  E M LINCOLN
Journal:  Am Rev Tuberc       Date:  1951-11

4.  Course and prognosis of tuberculosis in children.

Authors:  E M LINCOLN
Journal:  Am J Med       Date:  1950-11       Impact factor: 4.965

5.  Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing.

Authors:  L P Ormerod
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

6.  Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children.

Authors:  K H Hsu
Journal:  JAMA       Date:  1974-07-29       Impact factor: 56.272

7.  [Epidemiological indices for the planning, supervision, and evaluation of antituberculosis programs].

Authors:  K Styblo; I Sutherland
Journal:  Bull Int Union Tuberc       Date:  1974

8.  [Significance of endogenous reactivation. 30 years' observation of subjects whose tuberculin test reaction has changed].

Authors:  Y Chiba
Journal:  Bull Int Union Tuberc       Date:  1974
  8 in total
  4 in total

1.  Indian Journal of Pediatrics: journey of eight decades.

Authors:  I C Verma; S K Kabra
Journal:  Indian J Pediatr       Date:  2014-01-09       Impact factor: 1.967

2.  Tubercular lymphadenitis: clinical manifestations.

Authors:  V Seth; S K Kabra; Y Jain; O P Semwal; S Mukhopadhyaya; R L Jensen
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

3.  Tuberculosis of the urachal cyst.

Authors:  Tarun Jindal; Mir Reza Kamal; Jayesh Kumar Jha
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

Review 4.  BCG vaccination in India and tuberculosis in children: newer facets.

Authors:  P M Udani
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.